The FDA weigh up mandatory education for opioid prescribers; There’s an increase in the sale of strong psychoactive THC products; Brukinsa and Exkivity gain approval, respectively; And a number of supplement companies received FDA warning letters.
Review finds no beneficial effects on muscle function, strength, or mass
Secondary analysis of randomized trial shows no difference in progression of KDIGO risk scores with daily vitamin D versus placebo
Risk for COVID-19 infection greater among U.S. Black women with serum levels of vitamin D lower than 20 ng/mL
Associations strongest for flavones, flavanones, anthocyanins; dose-response curve steepest for flavones, then anthocyanins
Patients with the highest levels of EPA had similar rates of major adverse cardiovascular events as patients taking placebo
DMAA constricts blood vessels and arteries, leading to increased blood pressure and cardiovascular problems.
Task force recommends against use of beta-carotene, vitamin E for prevention of cardiovascular disease or cancer in adults
Ascorbic acid level testing confirmed severe deficiency (<0.1mg/dL).
The recalled products were distributed from November 13, 2020 through April 9, 2021 to in-store and e-commerce retailers.
